DE3778002D1 - Methode zur behandlung von plasma und dessen produkten. - Google Patents

Methode zur behandlung von plasma und dessen produkten.

Info

Publication number
DE3778002D1
DE3778002D1 DE8787101072T DE3778002T DE3778002D1 DE 3778002 D1 DE3778002 D1 DE 3778002D1 DE 8787101072 T DE8787101072 T DE 8787101072T DE 3778002 T DE3778002 T DE 3778002T DE 3778002 D1 DE3778002 D1 DE 3778002D1
Authority
DE
Germany
Prior art keywords
antibodies
receptors
blood
human blood
immunoabsorbent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787101072T
Other languages
German (de)
English (en)
Inventor
Harold C Mielke
Patrick J Scannon
Paul R Sohmer
John C Klock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Royalty Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of DE3778002D1 publication Critical patent/DE3778002D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8787101072T 1984-07-19 1987-01-27 Methode zur behandlung von plasma und dessen produkten. Expired - Lifetime DE3778002D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/632,756 US4664913A (en) 1982-05-24 1984-07-19 Method for treating plasma for transfusion

Publications (1)

Publication Number Publication Date
DE3778002D1 true DE3778002D1 (de) 1992-05-07

Family

ID=24536816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787101072T Expired - Lifetime DE3778002D1 (de) 1984-07-19 1987-01-27 Methode zur behandlung von plasma und dessen produkten.

Country Status (7)

Country Link
US (1) US4664913A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0276342B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE74282T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU596392B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3778002D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2032276T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3004763T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
AU1074601A (en) * 1999-10-08 2001-04-23 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
EP1420641A4 (en) * 2001-08-01 2005-05-25 Anil K Chauhan IMMUNE COMPLEX
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
EP1696940B1 (en) * 2003-12-19 2007-03-21 Octapharma AG A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
RU2378016C2 (ru) * 2004-04-30 2010-01-10 Байофересиз Текнолоджиз, Инк. Способ и система для удаления у пациентов растворимых tnfr1, tnfr2 и il2
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US8449520B2 (en) * 2007-03-19 2013-05-28 HemCon Medical Technologies Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US7776022B2 (en) * 2007-03-19 2010-08-17 Hemcon Medical Technologies Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
WO2020242552A1 (en) 2019-03-14 2020-12-03 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533440A1 (fr) * 1982-09-24 1984-03-30 Inst Nat Sante Rech Med Dispositif pour l'elimination ou la recuperation de substances biologiquement actives a partir du sang, son obtention et son utilisation
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens

Also Published As

Publication number Publication date
AU6804987A (en) 1988-08-04
US4664913A (en) 1987-05-12
ATE74282T1 (de) 1992-04-15
GR3004763T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-28
US4664913B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-01-30
EP0276342A1 (en) 1988-08-03
ES2032276T3 (es) 1993-02-01
EP0276342B1 (en) 1992-04-01
AU596392B2 (en) 1990-05-03

Similar Documents

Publication Publication Date Title
DE3778002D1 (de) Methode zur behandlung von plasma und dessen produkten.
US4444887A (en) Process for making human antibody producing B-lymphocytes
Osterland et al. Anti‐γ‐globulin factors in human sera revealed by enzymatic splitting of anti‐Rh antibodies
Ishizaka et al. Identification of γE-antibodies as a carrier of reaginic activity
van Boxel et al. IgD-bearing human lymphocytes
Akeson et al. Modulation of cell-surface antigens of a murine neuroblastoma
US4411993A (en) Hybridoma antibody which inhibits interleukin 2 activity
ES515177A0 (es) Procedimiento para el tratamiento de inmunoglobulina de suero.
Christian Rheumatoid factor properties of hyperimmune rabbit sera
Sandberg et al. Initiation of bone resorption by the classical and alternative C pathways and its mediation by prostaglandins
Awdeh et al. The homogenous γG-immunoglobulin produced by mouse plasmacytoma 5563 and its subsequent heterogeneity in serum
Yamamoto et al. The human LT system: II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro
Misiti et al. In vitro generation of antigen-specific hemolytic plaque-forming cells from human peripheral blood mononuclear cells.
US4346029A (en) Antiplasmin and antiserum
Dehm et al. Antibodies to Chick‐Tendon Procollagen: Affinity Purification with the Isolated Disulfide‐Linked NH2‐Terminal Extensions and Reactivity with a Component in Embryonic Serum
EP0131424B1 (en) Improvements in or relating to antibody preparations
Barker et al. Purification and quantification of T and B lymphocytes by an affinity method
Okita et al. Immunofluorescent study of chromatin proteins in cultured fibroblasts
Regnault et al. Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: optimization of an immunoadsorption procedure
Mammen et al. Thrombophlebitis migrans associated with circulating antibodies against fibrinogen
Ito et al. Studies on IgE fragments prepared by papain digestion
Amemiya et al. The nature of antiplatelet activity in antilymphoblast ALG: with special reference to crossreacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients
Aho et al. An inhibitor of the complement-fixation reaction associated with interferon treatment
Bartoloni et al. Immunochemical and ultrastructural study of multiple myeloma with a heavy chain protein in the serum.
Thiel et al. Isolation of the Major Glycoprotein (gp70) of Simian Sarcoma Virus (SSV-1/SSAV-1) in Preparative Quantities

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee